Meningococcal disease is caused by Neisseria meningitidis and can present as bloodstream infection or meningitis, both of which can progress rapidly and be fatal within hours. Transmission requires close or prolonged contact, with spread through respiratory and throat secretions such as saliva.
Common presenting features include fever, headache, and neck stiffness; additional symptoms may include altered mental status, nausea, photophobia, vomiting, and a purpuric or dark purple rash. Prevention centers on vaccination; vaccination is recommended for individuals at increased risk during an outbreak.
For persons exposed to an infected individual, prophylactic antibiotics may be advised. Outcomes remain serious: even with antibiotic treatment, mortality ranges from 10 to 15%.
Among survivors, about 20% experience long-term disabilities. Uncertainties: the source provides general statements without region-specific data for the Democratic Republic of the Congo beyond the title; no local incidence, serogroup distribution, or vaccine coverage details are provided.
Clinicians should consult current CDC travel advisories and local public health guidance for outbreak status and vaccination recommendations specific to travelers and residents.